| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/21/2007 | CN1305895C Method for synthesizing thymic-pentapeptide by mixing acid anhydride method |
| 03/20/2007 | US7193040 Apoptosis of rectum and prostate cancer |
| 03/20/2007 | US7193038 Nontoxic, stable polypeptide used as cellular adhesion molecules, wound healing agents, cosmetics,and cell culture substrates |
| 03/20/2007 | US7193034 Synthetic peptides, conjugation reagents and methods |
| 03/20/2007 | US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192928 T cell antigen receptor peptides |
| 03/20/2007 | US7192927 An isolated BAX gene frameshift-mutation polypeptide is used to stimulate the proliferation of human T cells, T cellular immunity; for treating cancer patient; cancer vaccines |
| 03/20/2007 | US7192921 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 03/20/2007 | US7192920 Fungicides trans 1-[4-[(2-aminocyclo-hexyl)-amino]N2-[[4''(pentyloxy)[1,1':4', 1''-terphenyl]-4-yl-carbonyl]-L-ornithine]-4-[4(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandine B trifluoroacetate; treating infections caused by Candida, Aspergillus, Cryptococcus |
| 03/20/2007 | US7192742 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages |
| 03/20/2007 | US7192723 useful as drugs for the prevention and treatment of various diseases, in terms of prolactin secretion inhibitors uch as pituitary tumor, diencephalon tumor, menstrual disorder, autoimmune diseases, prolactinoma, sterility, impotence |
| 03/20/2007 | US7192595 Peptide-based vaccine for influenza |
| 03/20/2007 | US7192570 Compositions of somatostatin analogues |
| 03/15/2007 | WO2007030804A1 Prion-specific peptoid reagents |
| 03/15/2007 | WO2007029778A1 Hla-binding peptide, dna fragment encoding the peptide, and recombinant vector |
| 03/15/2007 | WO2007028969A2 Anchoring disruption molecules |
| 03/15/2007 | WO2007028219A1 Epitopes, combined epitopes, use of epitopes or their combination, composition, uses of the composition, anti- hiv-i prophylactic vaccines, therapeutic vaccines, method for the identification of epitopes and methods for treatment and prevention |
| 03/15/2007 | WO2006132925A3 Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy |
| 03/15/2007 | WO2006021942A3 Platelet modulating oligopeptides |
| 03/15/2007 | US20070060527 Orally administered small peptides synergize statin activity |
| 03/15/2007 | US20070060524 Analogs of peptides corresponding to class I major histocompatibility complex (MHC)-restricted T-cell epitopes that contain amino acid substitutions of norleucine and/or norvaline; intranodal administration a an immunopotentiating agent |
| 03/15/2007 | US20070060522 Soluble fibrin inhibitory peptides and uses thereof |
| 03/15/2007 | US20070060514 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/15/2007 | US20070060508 Binding molecules |
| 03/15/2007 | US20070059800 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 03/15/2007 | US20070059799 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 03/15/2007 | US20070059792 convergent assembly of a plurality of pairs of oligopeptides; stable C-terminal disulfide-protected carboxythioester group that can be deprotected to spontaneously generate a free C-terminal thioester; allows a single precursor to participate in a succession of chemical ligation reactions |
| 03/15/2007 | US20070059756 Immunointeractive molecules and their uses in treating subjects suffering from Hev b 5 allergies |
| 03/15/2007 | US20070059755 Screening peptide library; incubation; complexing |
| 03/15/2007 | US20070059320 Method for ameliorating pain by modification of NMDA receptors through inhibition of Src |
| 03/15/2007 | CA2621767A1 Prion-specific peptoid reagents |
| 03/15/2007 | CA2621272A1 Anchoring disruption molecules |
| 03/14/2007 | EP1761783A2 Identification of compounds modifying a cellular response |
| 03/14/2007 | EP1761631A1 Use of mycobacterial mannosylated lipoglycans peptide mimotopes for treating inflammation |
| 03/14/2007 | EP1761560A1 Peptide-based compounds |
| 03/14/2007 | EP1761554A2 Peptide antibiotics and methods for making same |
| 03/14/2007 | EP1761553A2 Tumor-associated peptides that bind to mhc-molecules |
| 03/14/2007 | EP1224302B1 Modified viral surface proteins which bind to cells of tumor vasculature |
| 03/14/2007 | EP1112057B1 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 03/14/2007 | EP0698089B1 Nucleic acid encoding amp-activated protein kinase |
| 03/14/2007 | CN1927882A Sugar conjugated protein with resistant action of human acquired immunity system synthesis disease virus activity |
| 03/14/2007 | CN1927880A Odorranagrahami antimicrobialpeptides and application thereof |
| 03/14/2007 | CN1927879A Thymopentapeptide active isomer and application thereof in pharmaceutical preparation |
| 03/14/2007 | CN1304420C Antigen simulating epipeptide of C type para chicken blood phili bacillus and its use |
| 03/14/2007 | CN1304419C Antigen simulating epipeptide of A type parachicken blood phili bacillus and its use |
| 03/14/2007 | CN1304418C Nuclear factor-K B P65 subunit antagonistic peptide and its use |
| 03/14/2007 | CN1304417C Intermediates for LHRH antagonist synthesis, process for their production, and process for LHRH antagonist production |
| 03/14/2007 | CN1304363C N-methyl-homocysteines and their use as well as process for their production |
| 03/14/2007 | CN1304362C Prepn process of metal-amino acid chelate |
| 03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
| 03/13/2007 | US7189696 Peptide antagonists of zonulin and methods for use of the same |
| 03/13/2007 | US7189694 Inhibitors of autophosphorylation protein kinases |
| 03/13/2007 | US7189692 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 03/13/2007 | US7189691 Methods and compositions for treating leukemia |
| 03/13/2007 | US7189689 Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders |
| 03/13/2007 | US7189523 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein |
| 03/13/2007 | CA2235398C Expression system in microorganism and its use for expressing heterologous and homologous proteins |
| 03/08/2007 | WO2007027574A2 Cyclic peptide isolation by spray drying |
| 03/08/2007 | WO2007026120A2 Preprotachykinin enhancer elements |
| 03/08/2007 | WO2007025390A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 03/08/2007 | WO2007025366A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
| 03/08/2007 | WO2007025332A1 A peptide and zinc ion composition for treating diabetes and enhancing immune function |
| 03/08/2007 | WO2006103666A3 Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis |
| 03/08/2007 | US20070054863 modulators of Bcl-2 genes and proteins, comprising a mixture of a pro-apoptotic peptide and a cell-penetrating-peptide, that induces apoptosis of mammalian cells expressing Bcl-2 genes or Bcl-2 related proteins, used for for treatment of proliferative diseases and neurodegenerative diseases |
| 03/08/2007 | US20070054848 Composition and method for nerve regeneration |
| 03/08/2007 | US20070054840 Template-fixed peptidomimetics with antimicrobial activity |
| 03/08/2007 | US20070054315 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for producing the complex structure |
| 03/08/2007 | US20070054262 Methods of identifying optimal variants of peptide epitopes |
| 03/08/2007 | US20070053837 Radiopharmaceuticals for cancer diagnosis and treatment |
| 03/08/2007 | DE102005041616A1 Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und deren Verwendungen Melanoma-associated MHC class I-associated oligopeptides and their uses |
| 03/08/2007 | CA2625940A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
| 03/08/2007 | CA2620935A1 Method of using pore-forming peptides for genetic transformation, protein extraction, and transmembrane transport |
| 03/08/2007 | CA2620774A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 03/07/2007 | EP1760090A1 Regulatory/unfolding peptides of ezrin |
| 03/07/2007 | EP1759212A1 Identification of compounds modifying a cellular response |
| 03/07/2007 | EP1758931A1 Peptides derived from decorin leucine rich repeats and uses thereof |
| 03/07/2007 | EP1758924A1 Peptides antagonists for inhibiting heat shock protein (hsp 16.3) of mycobacterium tuberculosis |
| 03/07/2007 | EP1758677A2 Peptide purification by means of hard metal ion affinity chromatography |
| 03/07/2007 | EP1279677B1 Gd3-mimetic peptides |
| 03/07/2007 | EP1131348B1 Regulatory/unfolding peptides of ezrin |
| 03/07/2007 | CN1926149A Identification of novel IgE epitopes |
| 03/07/2007 | CN1925841A Pharmaceutical preparation for the oral cavity |
| 03/07/2007 | CN1923849A Preparation method of synthesizing octriotide from solid phase polypeptide |
| 03/07/2007 | CN1303101C Small peptide sequence of combined site between envelope protein E2 of close hepatitis C virus and human CD81 |
| 03/06/2007 | US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors |
| 03/06/2007 | US7186799 Binding amine to polypeptide; analyzing, calibration |
| 03/06/2007 | US7186798 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 03/06/2007 | US7186514 Nucleotide sequences coding tumor marker protein for use in diagnosis and/or prognosis of cell proliferative disorders |
| 03/06/2007 | CA2320488C Strategically modified hepatitis b core proteins and their derivatives |
| 03/06/2007 | CA2141670C Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 03/01/2007 | WO2007025181A2 Aureobasidin a synthetase |
| 03/01/2007 | WO2007024817A2 Soluble fibrin inhibitory peptides and uses thereof |
| 03/01/2007 | WO2007023930A1 Brain-migrating cell and use thereof |
| 03/01/2007 | WO2007023782A1 Neutralizing antibody directed against killer toxin-like protein, and use thereof |
| 03/01/2007 | WO2007022557A1 Mimotopes of epstein-barr virus (ebv) epitopes |
| 03/01/2007 | WO2007002811A3 Methods and compositions for treating melanoma |
| 03/01/2007 | WO2006083317A9 Peptide antibiotics and methods for making same |
| 03/01/2007 | WO2006074466A3 Synthesis of epoxide based inhibitors of cysteine proteases |
| 03/01/2007 | WO2006072048B1 Compositions and methods for identifying modulators of hausp |